An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1

Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.